HDAC1/2 maintain TERT mRNA stability in TERT-rearranged neuroblastoma

Genomic TERT locus rearrangements define an aggressive high-risk neuroblastoma subgroup characterized by enhancer hijacking, high-level TERT expression and continuous telomerase activation. Although these structural alterations supply a strong transcriptional drive, the post-transcriptional mechanisms preserving TERT mRNA presence remain incompletely understood. We identified histone deacetylases 1 and 2 (HDAC1/2) as essential post-transcriptional guardians of TERT mRNA stability in TERT-rearranged neuroblastoma. Pharmacological inhibition or RNAi-mediated depletion of HDAC1 and HDAC2, but not HDACs 3-11, rapidly downregulated TERT transcript levels and suppressed telomerase enzymatic activity. Transcript decay kinetics following transcriptional arrest with actinomycin D confirmed that HDAC1/2 blockade accelerates TERT mRNA decay, reducing transcript half-life by 30-47%. High-resolution ChIP-seq profiling across the translocation breakpoint demonstrated HDAC inhibition does not alter local chromatin accessibility. Array-based DNA methylation profiling showed only a mild, non-specific global reduction in CpG island methylation upon panobinostat exposure and no focal correlation with TERT transcript loss across the breakpoint locus. Depleting TERT mRNA via HDAC1/2 inhibition dismantled a core 50-gene TERT-associated oncogenic expression network. Ectopic re-expression of TERT cDNA partially rescued cellular viability and normalized expression of key signature genes despite continuous HDAC inhibition. HDAC1/2 inhibition significantly attenuated tumor growth, reduced intratumor TERT expression and prolonging overall survival in both preventive and therapeutic TERT-rearranged xenograft mouse models. Our data establish a post-transcriptional rather than transcriptional mode of TERT regulation and confirm tumor suppression is partly driven by depleting TERT transcripts, uncovering a HDAC1/2 dependency in TERT-driven neuroblastoma. We provide a molecular rationale for therapeutic strategies disrupting HDAC1/2-mediated TERT mRNA stabilization.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.15.766789
Primary Topic
Neuroblastoma Research and Treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

HDAC1/2 maintain TERT mRNA stability in TERT-rearranged neuroblastoma

Anton George Henssen, Annika Spruessel, Annabell Szymansky, Charlotte Gatzweiler et al.
bioRxiv (Cold Spring Harbor Laboratory)
Neuroblastoma Research and Treatments
preprint

HDAC1/2 maintain TERT mRNA stability in TERT-rearranged neuroblastoma

Anton George Henssen, Annika Spruessel, Annabell Szymansky, Charlotte Gatzweiler, Rocío Chamorro González, Kathrin Hauptmann, Konstantin Helmsauer, January Mikolaj Weiner, Steffen Fuchs, Sabine Finkler, Hedwig E. Deubzer, Marco Lodrini, Angelika Eggert, Dieter Beule, Jan F. Hollander, Sveva Castelli, Anja A. Kuehl, Franziska Schulze, Nils Bluethgen
preprint en

Abstract

Genomic TERT locus rearrangements define an aggressive high-risk neuroblastoma subgroup characterized by enhancer hijacking, high-level TERT expression and continuous telomerase activation. Although these structural alterations supply a strong transcriptional drive, the post-transcriptional mechanisms preserving TERT mRNA presence remain incompletely understood. We identified histone deacetylases 1 and 2 (HDAC1/2) as essential post-transcriptional guardians of TERT mRNA stability in TERT-rearranged neuroblastoma. Pharmacological inhibition or RNAi-mediated depletion of HDAC1 and HDAC2, but not HDACs 3-11, rapidly downregulated TERT transcript levels and suppressed telomerase enzymatic activity. Transcript decay kinetics following transcriptional arrest with actinomycin D confirmed that HDAC1/2 blockade accelerates TERT mRNA decay, reducing transcript half-life by 30-47%. High-resolution ChIP-seq profiling across the translocation breakpoint demonstrated HDAC inhibition does not alter local chromatin accessibility. Array-based DNA methylation profiling showed only a mild, non-specific global reduction in CpG island methylation upon panobinostat exposure and no focal correlation with TERT transcript loss across the breakpoint locus. Depleting TERT mRNA via HDAC1/2 inhibition dismantled a core 50-gene TERT-associated oncogenic expression network. Ectopic re-expression of TERT cDNA partially rescued cellular viability and normalized expression of key signature genes despite continuous HDAC inhibition. HDAC1/2 inhibition significantly attenuated tumor growth, reduced intratumor TERT expression and prolonging overall survival in both preventive and therapeutic TERT-rearranged xenograft mouse models. Our data establish a post-transcriptional rather than transcriptional mode of TERT regulation and confirm tumor suppression is partly driven by depleting TERT transcripts, uncovering a HDAC1/2 dependency in TERT-driven neuroblastoma. We provide a molecular rationale for therapeutic strategies disrupting HDAC1/2-mediated TERT mRNA stabilization.

bioRxiv (Cold Spring Harbor Laboratory)
Institute for Research in Biomedicine (ES), Barcelona Institute of Science and Technology (ES), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Deutsches Krebsforschungszentrum, European Commission, Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Good health and well-being
Neuroblastoma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon